Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Paget Disease, Extramammary × toripalimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Nasopharyngeal Carcinoma 17 Carcinoma, Non-Small-Cell Lung 15 Esophageal Squamous Cell Carcinoma 14 Breast Neoplasms 12 Triple Negative Breast Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 11 Small Cell Lung Carcinoma 8 Carcinoma, Hepatocellular 8 Stomach Neoplasms 7 Recurrence 6 Uterine Cervical Neoplasms 5 Head and Neck Neoplasms 5 Colorectal Neoplasms 5 Sarcoma 4 Neoplasm Metastasis 4 Melanoma 4 Laryngeal Neoplasms 4 Hypopharyngeal Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Renal Cell 4 Rectal Neoplasms 3 Locally Advanced Rectal Cancer 3 Urinary Bladder Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Oropharyngeal Neoplasms 2 NSCLC 2 Microsatellite Stable Metastatic Colorectal Cancer 2 Liver Neoplasms 2 Klatskin Tumor 2

Interventions

Specimen Handling 2 Nivolumab 2 toripalimab 1 talimogene laherparepvec 1 bicalutamide 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Fluorescein 1 CTLA-4 Antigen 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06791070 2025-01-24

RC48&J for EPD

Fujian Medical University Union Hospital

Phase 2 Recruiting

Paget Disease, Extramammary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡